Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinically Isolated Demyelinating Syndromes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06395909
What this trial is testing

Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Relapsing Multiple SclerosisClinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis+1 more
Novartis 113
Not applicableNot Yet RecruitingNCT07280871
What this trial is testing

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic ProgressiveClinically Isolated Syndrome+1 more
Luxembourg Institute of Health 100
Post-approval studies (Phase 4)UnknownNCT00910598
What this trial is testing

Optical Coherence Tomography: Glatiramer in Clinically Isolated Syndrome or Early Relapsing Remitting Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Amphia Hospital 60
Not applicableActive Not RecruitingNCT06274671
What this trial is testing

Glymphatic MRI in Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated Syndrome
University of Exeter 30
Not applicableEnded earlyNCT01567553
What this trial is testing

The Inflammatory Process and the Medical Imaging in Patients With an Inflammatory Disease of the Central Nervous System.

Who this might be right for
Multiple Sclerosis (MS)Inflammatory Disease
Rennes University Hospital 37
Not applicableStudy completedNCT01737372
What this trial is testing

A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple Sclerosis

Who this might be right for
Multiple SclerosisSecondary Progressive Multiple SclerosisClinically Isolated Syndrome
John F. Foley, MD 49
Not applicableLooking for participantsNCT04798651
What this trial is testing

Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome
University Hospital, Bordeaux 150
Not applicableStudy completedNCT01112657
What this trial is testing

An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 154
Post-approval studies (Phase 4)Study completedNCT03269175
What this trial is testing

BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies

Who this might be right for
Multiple Sclerosis
Bayer 261
Not applicableActive Not RecruitingNCT05057676
What this trial is testing

Autoimmune Intervention Mastery Course Study

Who this might be right for
Multiple SclerosisClinically Isolated SyndromeFibromyalgia+2 more
Terry L. Wahls 400
Not applicableStudy completedNCT06737419
What this trial is testing

Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 175
Not applicableStudy completedNCT03451955
What this trial is testing

The Effect of a Gluten Free Diet on the Permeability of the Blood Brain Barrier in Patients With CIS

Who this might be right for
Optic NeuritisMultiple SclerosisClinically Isolated Syndrome
University of Copenhagen 103
Large-scale testing (Phase 3)Study completedNCT01167426
What this trial is testing

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 148
Testing effectiveness (Phase 2)Looking for participantsNCT05418010
What this trial is testing

Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)

Who this might be right for
Multiple SclerosisClinically Isolated Syndrome of Demyelination
Queen Mary University of London 40
Not applicableUnknownNCT03979391
What this trial is testing

Isoelectric Focusing of Tears in Children With Radiologically Isolated or Clinically Isolated Syndrome

Who this might be right for
Clinically Isolated SyndromeRadiologically Isolated SyndromeMultiple Sclerosis in Children
Lille Catholic University 20
Not applicableStudy completedNCT00232193
What this trial is testing

Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS

Who this might be right for
Relapsing-remitting Multiple SclerosisClinically Isolated Syndrome
Providence Multiple Sclerosis Center 40
Not applicableUnknownNCT05277740
What this trial is testing

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

Who this might be right for
Clinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis
McGill University 120
Large-scale testing (Phase 3)Study completedNCT02746744
What this trial is testing

RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Anders Svenningsson 200
Not applicableLooking for participantsNCT06940323
What this trial is testing

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

Who this might be right for
Multiple SclerosisClinically Isolated SyndromeNMOSD+1 more
University of California, San Francisco 250
Not applicableUnknownNCT03610139
What this trial is testing

Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingClinically Isolated Syndrome+2 more
American University of Beirut Medical Center 162
Next Page